Navigation Links
Neptune Product and Distribution Update

LAVAL, QC, May 5 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides an update on business activities regarding its product portfolio.

    Worldwide Sales and Distribution Update

    - Neptune expanded its sales and marketing team through the hiring of two
      additional marketing and sales executives with longstanding, well-
      recognized backgrounds in the nutraceutical and functional food
    - North America: Neptune entered into a new distribution agreement with
      Inno-Vite, a Canadian leader in innovative health products focusing on
      research-proven ingredients. Inno-Vite launched Neptune Krill Oil
      NKO(R) under the brand name Inno-Krill(TM) in health food stores across
      Canada. Neptune is preparing further market entrance with additional
      distributors in order to strengthen its position in the Canadian
    - South Africa: Vital Health Foods, South Africa's leading health food
      company, distributes Natrodale NKO(R). Presently, Natrodale is
      positioned as one of South Africa's most established vitamin and health
      supplement brands.
    - Europe: Weifa, a leading pharmaceutical company, launched NKO(R) for
      the first time in the Norwegian market in drug stores for women's

    Launch at Vitafoods International, May 2009

    - Neptune presents novel innovative product opportunities customized for
      dietary supplements, functional and medical foods at Vitafoods
      International 2009. Vitafoods is Europe's largest event for the
      nutraceutical, cosmeceutical and functional food ingredients industry.
    - Neptune launches a new pipeline of novel formulations containing its
      proprietary marine omega-3 phospholipids enhanced with validated
      bioactive ingredients targeted to specific health applications. The
      Company is also testing the industry's reception of a new biomass
      extract generated from Neptune's research and development program
      targeting new vascular and affective health indications.
    - Neptune will also be presenting pilot commercial products for
      functional food applications including juice, fruit berries, fruit
      paste and protein bars.

    Intellectual Property and Regulatory Affairs

    Neptune is continuously strengthening its competitive advantage and
leverages itself by expanding its portfolio of intellectual property and
regulatory approvals, thereby executing on its strategy to effectively limit
competitors from penetrating word markets.

    - Australia: Neptune has received notification that its composition of
      matter patent has been issued. The patent protection and the
      complementary medicine approval, including the approved compositional
      guidelines, effectively preclude competitors from entering the market.
    - Europe: Neptune is pursuing a similar competitive strategy of limiting
      legal competitive entry through its granted and issued patents combined
      with European approval specific to commercialization of Neptune
    - Canada: The Natural Health Product Directorate of Health Canada granted
      Neptune an 8-digit natural product number (NPN) to be listed on product
      labels, which informs consumers that the product has been reviewed by
      Health Canada for safety, quality and health claims.
    - U.S.: Neptune has received US FDA GRAS ("generally recognized as safe")
    - Middle East: In preparation for market entrance, the Islamic Food and
      Nutrition Council of America has certified that NKO(R) is produced

    About Neptune Technologies & Bioressources Inc.

    Neptune is the pioneer and leader in marine omega-3 phospholipids, which
are the highest quality Omega-3s available in the market, clinically shown to
be effective in cholesterol management, joint health, inflammation and
cognitive function. Neptune Krill Oil NKO(R) represents the first and only
clinically proven omega-3 phospholipids exhibiting unmatched safety, purity
and stability. NKO(R) omega-3 marine phospholipids set a new standard of
omega-3 excellence supported by a strong intellectual property portfolio and
multinational regulatory approvals. Neptune pursues market opportunities in
the nutraceutical markets (dietary supplement, functional food) and
pharmaceutical markets (OTC, medical food, Rx) through its subsidiaries Acasti
Pharma for cardiovascular applications and NeuroBioPharm for neurological

    NASDAQ does not accept responsibility for the adequacy or accuracy of
    this press release. Neither TSX Venture Exchange nor its Regulation
    Services Provider (as that term is defined in the policies of the TSX
    Venture Exchange) accepts responsibility for the adequacy or accuracy of
    this release.

Statements in this press release that are not statements of historical or current fact, including statments relating to the Company's expectation regarding the future performance and marketability of its products, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates,"should," "will" or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results
2. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
3. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
4. Neptune Technologies & Bioressources Inc. reports first quarter results
5. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
6. Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
7. Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
8. Neptune Technologies decided not to re-price options
9. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
10. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
11. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... The United States ... of the 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green ... or her work with turfgrass. , Clarke, of Iselin, N.J., is an ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced broader entry into the automotive market ... that match the pace of consumer electronics human interface ... sensors are ideal for the automotive industry and will ... Europe , Japan ...
(Date:10/29/2015)... 29, 2015 Daon, a global leader in ... released a new version of its IdentityX Platform ... North America have already installed IdentityX v4.0 ... a FIDO UAF certified server component as ... activate FIDO features. These customers include some of the ...
Breaking Biology News(10 mins):